These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 21186631)

  • 21. Induction of p21WAF1 expression via Sp1-binding sites by tamoxifen in estrogen receptor-negative lung cancer cells.
    Lee TH; Chuang LY; Hung WC
    Oncogene; 2000 Aug; 19(33):3766-73. PubMed ID: 10949931
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protein Kinase C alpha is a marker for antiestrogen resistance and is involved in the growth of tamoxifen resistant human breast cancer cells.
    Frankel LB; Lykkesfeldt AE; Hansen JB; Stenvang J
    Breast Cancer Res Treat; 2007 Aug; 104(2):165-79. PubMed ID: 17061041
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isolated and combined action of tamoxifen and metformin in wild-type, tamoxifen-resistant, and estrogen-deprived MCF-7 cells.
    Berstein LM; Yue W; Wang JP; Santen RJ
    Breast Cancer Res Treat; 2011 Jul; 128(1):109-17. PubMed ID: 20683653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Erythropoietin fails to interfere with the antiproliferative and cytotoxic effects of antitumor drugs.
    Gewirtz DA; Di X; Walker TD; Sawyer ST
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2232-8. PubMed ID: 16609039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of tamoxifen in combination with cisplatin on oral squamous cell carcinoma cell lines.
    Kim MJ; Lee JH; Kim YK; Myoung H; Yun PY
    Cancer Lett; 2007 Jan; 245(1-2):284-92. PubMed ID: 16513256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of histone deacetylase enhances the anti-proliferative action of antiestrogens on breast cancer cells and blocks tamoxifen-induced proliferation of uterine cells.
    Hodges-Gallagher L; Valentine CD; Bader SE; Kushner PJ
    Breast Cancer Res Treat; 2007 Nov; 105(3):297-309. PubMed ID: 17186358
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Melittin inhibits proliferation and induces apoptosis of malignant human glioma cells].
    Yang ZL; Ke YQ; Xu RX; Peng P
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Nov; 27(11):1775-7. PubMed ID: 18024312
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of simulated microgravity on proliferation and chemosensitivity in malignant glioma cells.
    Takeda M; Magaki T; Okazaki T; Kawahara Y; Manabe T; Yuge L; Kurisu K
    Neurosci Lett; 2009 Sep; 463(1):54-9. PubMed ID: 19628020
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activated JNK brings about accelerated apoptosis of Bcl-2-overexpressing C6 glioma cells on treatment with tamoxifen.
    Moodbidri MS; Shirsat NV
    J Neurochem; 2005 Jan; 92(1):1-9. PubMed ID: 15606891
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protein kinase C inhibitors induce apoptosis in human malignant glioma cell lines.
    Couldwell WT; Hinton DR; He S; Chen TC; Sebat I; Weiss MH; Law RE
    FEBS Lett; 1994 May; 345(1):43-6. PubMed ID: 8194597
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polyoxygenated 24,28-epoxyergosterols inhibiting the proliferation of glioma cells from sea anemone Anthopleura midori.
    Yu S; Ye X; Chen L; Lian XY; Zhang Z
    Steroids; 2014 Oct; 88():19-25. PubMed ID: 24973636
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum-dependent effects of tamoxifen and cannabinoids upon C6 glioma cell viability.
    Jacobsson SO; Rongård E; Stridh M; Tiger G; Fowler CJ
    Biochem Pharmacol; 2000 Dec; 60(12):1807-13. PubMed ID: 11108795
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent advances in understanding the molecular mechanisms of tamoxifen action.
    Friedman ZY
    Cancer Invest; 1998; 16(6):391-6. PubMed ID: 9679530
    [No Abstract]   [Full Text] [Related]  

  • 34. A new mechanism of action for tamoxifen.
    Lipov EG; Joshi JR; Sanders S
    Lancet Oncol; 2009 Jun; 10(6):542. PubMed ID: 19482246
    [No Abstract]   [Full Text] [Related]  

  • 35. [The search for active antitumor agents among triphenylethylene derivatives].
    Sergeev PV; Savel'eva GM; Solov'eva EV; Grinenko GS; Kappusheva LM; Kareva EN
    Vopr Onkol; 1995; 41(2):49. PubMed ID: 7483433
    [No Abstract]   [Full Text] [Related]  

  • 36. A tamoxifen receptor within a voltage-gated sodium channel.
    Sula A; Hollingworth D; Ng LCT; Larmore M; DeCaen PG; Wallace BA
    Mol Cell; 2021 Mar; 81(6):1160-1169.e5. PubMed ID: 33503406
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The inhibitory effects of tamoxifen on glioma cells SHG-44].
    Wang S; Jiao BH
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2009 Feb; 25(1):111-2, 144. PubMed ID: 21186631
    [No Abstract]   [Full Text] [Related]  

  • 38. [The inhibition of tamoxifen on sodium channel in SHG-44 glioma cell-line].
    Wang S; Jiao BH
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2009 May; 25(2):207-10. PubMed ID: 21189553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Agents with selective estrogen receptor (ER) modulator activity induce apoptosis in vitro and in vivo in ER-negative glioma cells.
    Hui AM; Zhang W; Chen W; Xi D; Purow B; Friedman GC; Fine HA
    Cancer Res; 2004 Dec; 64(24):9115-23. PubMed ID: 15604281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Troglitazone enhances tamoxifen-induced growth inhibitory activity of MCF-7 cells.
    Yu HN; Noh EM; Lee YR; Roh SG; Song EK; Han MK; Lee YC; Shim IK; Lee SJ; Jung SH; Kim JS; Youn HJ
    Biochem Biophys Res Commun; 2008 Dec; 377(1):242-7. PubMed ID: 18835379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.